Regulatory Updates
🇺🇸 FDA Page 8FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 85–96 of 382 articles
FDA's Future: Insights from Former Commissioner David Kessler
FDA · 5 min
Dr. Sarah MitchellPharma in Focus: Regulatory Updates You Need to Know
FDA · 5 min
Dr. Sarah MitchellDrug Discovery USA 2026: What to Expect
FDA · 6 min
Dr. Sarah MitchellKailera's Triple-G Drug: A Potential Game-Changer in Pharma
FDA · 5 min
Dr. Sarah MitchellFDA Shakeup: Høeg's Departure and Amgen Drug Controversy
FDA · 5 min
Dr. Sarah MitchellFDA Approves First Oral COVID-19 PEP Drug, Xocova
FDA · COVID-19 · 4 min
Dr. Sarah MitchellPfizer sharpens prostate cancer case with Talzenna win — oncology
oncology · 5 min
Dr. Sarah MitchellExplaining Unapproved Drugs to Payors: FDA Guidance Helps Pharma Avoid Pitfalls
FDA · 7 min
Dr. Sarah MitchellAstraZeneca's Camizestrant: Navigating Divergent Regulatory Paths for Breast Cancer Treatment
FDA · breast cancer · 6 min
Dr. Sarah MitchellFDA Blueprint Aims to Reduce Regulatory Risks for Animal Testing Alternatives
FDA · 6 min
Dr. Sarah MitchellWhy Optimistic Scientists Are Losing Heart: Insights from MIT
FDA · 6 min
Dr. Sarah MitchellChina’s Rise in Drug Development Looms Over U.S. Oncology Market
FDA · oncology · 5 min
Dr. Sarah MitchellExplore intelligence